Diabetes Prevention Program Translation in the Veterans Health Administration

Autor: Moin, Tannaz, Damschroder, Laura J, AuYoung, Mona, Maciejewski, Matthew L, Datta, Santanu K, Weinreb, Jane E, Steinle, Nanette I, Billington, Charles, Hughes, Maria, Makki, Fatima, Holleman, Robert G, Kim, H Myra, Jeffreys, Amy S, Kinsinger, Linda S, Burns, Jennifer A, Richardson, Caroline R
Rok vydání: 2017
Předmět:
Adult
Male
Comparative Effectiveness Research
and promotion of well-being
Glycated Hemoglobin A
Clinical Trials and Supportive Activities
Veterans Health
Medical and Health Sciences
Education
Prediabetic State
Behavior Therapy
Clinical Research
Weight Loss
Diabetes Mellitus
80 and over
Humans
Electronic Health Records
Obesity
Prospective Studies
Exercise
Life Style
Metabolic and endocrine
Aged
Nutrition
Glycated Hemoglobin
Evidence-Based Medicine
Prevention
Body Weight
Diabetes
Middle Aged
Health Services
Prevention of disease and conditions
United States
Weight Reduction Programs
United States Department of Veterans Affairs
Treatment Outcome
Good Health and Well Being
Disease Progression
3.1 Primary prevention interventions to modify behaviours or promote wellbeing
Female
Public Health
Type 2
Zdroj: American journal of preventive medicine, vol 53, iss 1
Popis: IntroductionThis clinical demonstration trial compared the effectiveness of the Veterans Affairs Diabetes Prevention Program (VA-DPP) with an evidence-based usual care weight management program (MOVE!®) in the Veterans Health Administration health system.DesignProspective, pragmatic, non-randomized comparative effectiveness study of two behavioral weight management interventions.Setting/participantsObese/overweight Veterans with prediabetes were recruited from three geographically diverse VA sites between 2012 and 2014.InterventionVA-DPP included 22 group-based intensive lifestyle change sessions.Main outcome measuresWeight change at 6 and 12 months, hemoglobin A1c (HbA1c) at 12 months, and VA health expenditure changes at 15 months were assessed using VA electronic health record and claims data. Between- and within-group comparisons for weight and HbA1c were done using linear mixed-effects models controlling for age, gender, race/ethnicity, baseline outcome values, and site. Analyses were conducted in 2015-2016.ResultsA total of 387 participants enrolled (273 VA-DPP, 114 MOVE!). More VA-DPP participants completed at least one (73.3% VA-DPP vs 57.5% MOVE! p=0.002); four (57.5% VA-DPP vs 42.5% MOVE!, p=0.007); and eight or more sessions (42.5% VA-DPP vs 31% MOVE!, p=0.035). Weight loss from baseline was significant at both 6 (p
Databáze: OpenAIRE